Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats

Journal of Rheumatology

Volumn 23, Issue 12, 1996, Pages 2086-2091

  Seiffge, Dirk ^a,b  

^a SANOFI   (France)

^b Department of Project Group ^*  (Germany)

Author keywords

Adjuvant arthritis rats; Anti VLA 4; Arthritis index; Leukocyte adhesion; Monoclonal antibody

Indexed keywords

BETA1 INTEGRIN; MONOCLONAL ANTIBODY;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; CELL ADHESION; IMMUNOGLOBULIN G; INTEGRIN ALPHA4BETA1; INTEGRINS; LEUKOCYTES; MALE; MICE; RATS; RATS, WISTAR; RECEPTORS, LYMPHOCYTE HOMING;

EID: 0030474803     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Harris ED Jr: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Harris NR, Roussel JM, Grander DN: Mediators of endotoxin-induced leukocyte adhesion in mesenteric postcapillary venules. Circ Shock 1994;43:155-60.
3. Kurose I, Anderson DC, Miyasaka M, et al: Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994;74:336-43.
4. Harlan JM, Liu DY: Adhesion: Its role in inflammatory disease. New York: WH Freeman, 1992.
5. Postigo AA, Garcia-Vicuna R, Laffon A, Sanches-Madrid F: The role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Autoimmunity 1993;16:69-16.
6. Koch AE, Burreows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ: Immunolocalisation of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissue. Lab Invest 1991;64:313-20.
7. Hale LP, Martin ME, McCollum DE, et al: Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 1989;32:22-30.
8. Grober JS, Bowen BL, Ebling H, et al: Monocyte-endothelial adhesion in chronic rheumatoid arthritis: In situ detection of selectin and integrin-dependent interactions. J Clin Invest 1993;91:2609-19.
9. Szekanecz Z, Haines GK, Lin TR, et al: Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Arthritis Rheum 1994;37:221-31.
10. Kriegsmann J, Keyszer GM, Geiler T, et al: Expression of E-selectin messenger RNA and protein in rheumatoid arthritis. Arthritis Rheum 1995;38:750-4.
11. Kriegsmann J, Keyszer GM, Geiler T, Bräuer R, Gay RE, Gay S: Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 1995;72:209-14.
12. Streeter PS, Berg EL, Rouse BTN, Bargatze RF, Butcher EC: A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 1988;331:41-6.
13. Berlin C, Berg EL, Briskin MJ, et al: α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185-95.
14. Briskin MJ, McEvoy LM, Butcher EC: MAdCAM-1 displays homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 1993;363:461-4.
15. Berlin C, Bargatze RF, Campbell JJ, et al: α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-22.
16. Postigo AA, Teixido J, Sanchez-Madrid F: The α4β1/VCAM-1 adhesion pathway in physiology and disease. Res Immunol 1993;144:723-35.
17. Breedveld FC, Trentham DE: Progress in the understanding of inducible models of chronic arthritis. Rheum Dis Clin North Am 1987;13:531-44.
18. Smith-Oliver T, Noel LS, Stimpson SS, Yarnall DP, Connolly KM: Elevated levels of TNF in the joints of adjuvant arthritic rats. Cytokine 1993;5:298-304.
19. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: α4/β1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992;149:1424-31.
20. Issekutz AC, Issekutz BJ: Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J Exp Med 1995;181:1197-203.
21. Atherton A, Born GVR: Quantitative investigations of the adhesiveness of circulating polymorphonuclear leukocytes to blood vessel walls. J Physiol 1972;222:447-74.
22. Scriramarao P, von Andrian UH, Butcher EC, Bourdon MA, Broide DH: L-selectin and very late antigen-4 integrin promote rolling at physiological shear rates in vivo. J Immunol 1994,153:4238-46.
23. Newbould BB: Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol 1963;21:121-36.
24. Pearson CM: Development of arthritis, periarthritis, and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 1965;91:85-101.
25. Theisen-Popp P, Mueller-Peddinghaus R: Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis. Agents Actions 1994;42:50-5.
26. Fox JR, Wayland H: Interstitial diffusion of macromolecules in the rat mesentery. Microvasc Res 1979;18:255-76.
27. Wayland H, Johnson PC: Erythrocyte velocity measurement in microvessels by a two slit photometric method. J Appl Physiol 1967;22:333-7.
28. Intaglietta M, Tompkins WR, Richardson DR: Velocity measurements in the microvasculature. Microvasc Res 1970;2:462-73.
29. Baker M, Wayland H: On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 1974;7:131-43.
30. Seiffge D, Kremer E: Haemorheological long term study of adjuvant arthritic disease in rats. Clin Haemorheol 1983;3:469-80.
31. Crofford LJ, Wilder RL: Arthritis and autoimmunity in animals. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions. Philadelphia: Lea and Febiger, 1993:525-39.
32. Holzmann B, McIntyre BW, Weissman IL: Identification of murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4. Cell 1989;56:37-46.
33. Elices MJ, Osborn L, Takada Y, et al: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-84.
34. Jasin HE, Lightfoot E, Davis LS, Rothlein R, Foanes RB, Lipsky PE: Amelioration of antigen induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum 1992;35:541-52.
35. Chisholm PL, Williams CA, Lobb RR: Monoclonal antibodies to the integrin α-4 subunit inhibit the murine contact hypersensitivity response. Eur J Immunol 1993;23:682-92.
36. Weg VB, Williams TJ, Lobb RR, Nourshargh S: A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 1993;177:561-71.
37. Yednock TA, Cannon C, Fritz LC, Sánchez-Madrid F, Steinman L, Karin N: Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992;356:63-6.
38. Barbadillo C, G-Arroyo A, Salas C, Mulero J, Sánchez-Madrid F, Andreu JL: Anti-integrin immunotherapy in rheumatoid arthritis: Protective effect of anti-α4 antibody in adjuvant arthritis. Springer Semin Immunopathol 1995;16:427-36.